Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06539494
PHASE2

Luminal Fructose Kinetics (MARTINI Study)

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

View on ClinicalTrials.gov

Summary

In this study the investigators aim is to explore the dynamics of (small) intestinal fructose catabolism in humans and ethanol production in relation to small intestinal signalling pathways and changes in pH, using 13C fructose isotope tracing techniques complemented with direct luminal sampling via small intestinal catheter in biopsy proven MASLD/MASH patients vs healthy (BMI\<25) subjects. Additionally the investigators will repeat the experiment after four weeks of administering omeprazole at a dose of 40 mg twice daily. Omeprazole is a proton pump inhibitor, known to elevate pH from 2-6.

Official title: Luminal Fructose Kinetics (MARTINI) (2024)

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

22

Start Date

2024-07-01

Completion Date

2026-04

Last Updated

2024-08-06

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

Omeprazole 40 MG

Proton pump inhibitor twice a day for 4 weeks

Locations (1)

Amsterdam UMC location AMC

Amsterdam, Netherlands